Nevertheless, it is unclear whether cPOA or tPOA can ameliorate hypercholesterolemia by affecting the activity of LXRα and the downstream expression of NPC1L1 and CYP7A1. This evidence concerns the gene NR1H3 and familial hypercholesterolemia.